Elutia Inc. Class A Share Price

Elutia Inc. Class A Share Price

NASDAQ: ELUT | Micro Cap
$0.84
-$0.01 (-1.59%) Last updated on 31 Oct, 2026 | 01:23 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Elutia Inc. Class A Stock Performance

Open
$0.80
Prev. Close
$0.85
Circuit Range
N/A
Day Range
$0.80 - $0.85
Year Range
$0.51 - $1.39
Volume
3,999
Average Traded
$0.85

Elutia Inc. Class A Share Price Today

As of 31 October 2026, Elutia Inc. Class A's share price is $0.84. The stock opened at $0.80, compared to its previous close of $0.85. During today's trading session, Elutia Inc. Class A's share price traded between $0.80 and $0.85, with an average price of $0.83. Over the past 52 weeks, the stock has recorded a high of $1.39 and a low of $0.51. In terms of performance, Elutia Inc. Class A's share price has declined by 16.35% over the last six months and is down 7.26% on a year-on-year basis.

Elutia Inc. Class A Share Price Chart

Line chart of the Elutia Inc. Class A price trend over the selected period. The price fell overall, ranging from 0.80 to 0.86, ending at 0.84.
$0.80$0.85
L
Show Current Price
H

Elutia Inc. Class A Stock Fundamentals & Key Indicators

Market Cap
$34.65M
PE Ratio (TTM)
0.69
Dividend Yield
0.00%
EPS (TTM)
$1.17
Revenue (TTM)
$12.29B
Return On Equity (TTM)
329.02%
Profit Margin
434.34%
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-97.67%

Elutia Inc. Class A Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$3.32$3.27$3.11$2.43
Net Profit-$3.87$70.79-$7.47-$7.65
Net Profit Margin-116.57%2164.83%-240.19%-314.81%
Income ChangeN/A1929.20%-110.55%-2.41%

Elutia Inc. Class A Annual Profit & Loss

All figures in USD

Particulars202320242025
Revenue$24.75$14.47$12.29
Net Profit-$37.66-$53.95$53.38
Net Profit Margin-152.16%-372.84%434.34%
Income ChangeN/A-43.26%198.94%

About Elutia Inc. Class A

Elutia Inc develops proprietary drug-eluting biomatrix products for use in surgical reconstruction and related applications. These products are designed to improve the interaction between implanted medical devices and patients. Its products include CanGaroo, designed for implantable electronic devices, and SimpliDerm, used in soft tissue repair, with functions related to implant support and wound management. The company operates in two segments: Women's Health and Cardiovascular. The majority of revenue is derived from the Women's Health segment.

Elutia Inc. Class A Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Oct 2026
$0.68
$0.84
+3.34%
Sep 2026
$0.89
$0.81
-12.26%
Aug 2026
$0.83
$0.92
+8.47%
Jul 2026
$0.93
$0.85
-13.44%
Jun 2026
$1.14
$0.98
-15.34%
May 2026
$1.01
$1.16
+16.00%
Apr 2026
$1.10
$1.00
-2.91%
Mar 2026
$1.15
$1.03
-9.65%
Feb 2026
$1.01
$1.14
+8.57%
Jan 2026
$0.72
$1.05
+49.36%
Dec 2025
$0.65
$0.70
+14.68%
Nov 2025
$0.91
$0.61
-32.04%

ELUT Share Price FAQs